SS 46 - Right-Sizing Radiation in Early Breast Cancer: Omission, Shortening, and Targeted Approaches

Presentations

• 09:00am - 09:10am ET

  Initial Outcome Of The TARGIT-B International Randomised Trial Of Targeted Intraoperative Radiotherapy Tumour Bed Boost For Young Or High-Risk Patients With Breast Cancer

  Speaker: Jayant Vaidya, MD, MB, PhD, FRCS - University College London, London
• 09:10am - 09:20am ET

  Prospective Randomized study of Accelerated Radiation Therapy (PRART)

  Speaker: Fereshteh Talebi, MD - Weill Cornell Medical College, New York
• 09:20am - 09:30am ET

  Prospective Evaluation of a Once per Day Regimen of Accelerated Partial Breast Irradiation in Low-Risk, Hormone-Responsive Breast Cancer

  Speaker: Jose Bazan, MD, MS - City of Hope National Medical Center, Duarte
• 09:30am - 09:40am ET

  HER2-Low as an Independent Prognostic Entity in Node-Negative Early Breast Cancer: Implications for Classification and Adjuvant Treatment/Radiation De-Escalation

  Speaker: George Naoum, MD, MS - Memorial Sloan Kettering Cancer Center, New York
• 09:40am - 09:50am ET

  Validation of a Multi-Omic Biosignature in a Multi-Institutional Cohort to Predict Locoregional Recurrence Risk and Differential RT Effect In Early-Stage Invasive Breast Cancer

  Speaker: Atif Khan, MD, MS - Memorial Sloan Kettering Cancer Center, New York
• 09:50am - 10:00am ET

  Long-Term Follow-up of a Prospective Multicenter Trial of Endocrine Therapy without Radiotherapy after Breast-Conserving Surgery for Biologically Favorable Stage: Breast Cancers In Younger Postmenopausal Patients

  Speaker: Reshma Jagsi, MD, PhD, FASTRO - Emory University School of Medicine, Atlanta
• 10:00am - 10:10am ET

  Discussant

  Speaker: Lori Pierce, MD, FASTRO, FASCO, FAACR - University of Michigan, Ann Arbor